Jager Eline C, Brouwers Adrienne H, Metman Madelon J H, Aykan Dilay, de Vries Lisa H, Lodewijk Lutske, Vriens Menno R, Kruijff Schelto, Links Thera P
Department of Surgery, Division of Surgical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Department of Internal Medicine, Division of Endocrinology, University Medical Center Groningen, Groningen, The Netherlands.
Cancer Imaging. 2025 Mar 26;25(1):41. doi: 10.1186/s40644-025-00862-4.
While total thyroidectomy with central neck dissection (CND) is standard for medullary thyroid cancer (MTC), performing a lateral neck dissection (LND) depends on locoregional metastatic spread and is usually decided per individual. This study evaluated the utility of preoperative PET/CT in staging patients at diagnosis and guiding the initial surgical plan, while also exploring the value of neck ultrasound, MRI, and CT.
All MTC patients from two tertiary hospitals (2000 - 2020) were identified from two retrospective databases. All reports of neck ultrasounds, MRIs, CTs and PET/CTs < 8 months prior to primary surgery or < 4 months after MTC diagnosis were reviewed. The sensitivity and specificity of each imaging modality for locating locoregional lymph node metastases (LNM) was determined.
A total of 175 MTC patients were included (91 females and 57 hereditary MTCs). Median age at presentation was 52 years (IQR 38 - 62). Initial treatment included a total thyroidectomy, CND and LND in 155 (89%), 140 (80%) and 59 (33%) patients. Preoperative imaging of the neck included ultrasound (91, 52%), MRI (33, 19%) and CT (31, 18%). PET/CT imaging was performed in 56 (32%) patients (35 F-FDG PET/CTs and 33 F-DOPA PET/CTs). Sensitivity for LNM in the central compartment was 72%, 39%, 6%, 42% and 93% for F-FDG PET/CT, F-DOPA PET/CT, ultrasound, MRI and CT, respectively. Respective specificity rates were 80%, 100%, 100%, 71% and 100%. Sensitivity rates for lateral neck LNM were 89%, 81%, 77%, 76% and 75%, for F-FDG PET/CT, F-DOPA PET/CT, ultrasound, MRI and CT, while specificity rates were 100%, 100%, 75%, 78% and 50%, respectively. Twenty-three patients had distant metastases on imaging. In total, 14 F-FDG PET/CTs and 9 F-DOPA PET/CTs were made in these 23 patients (both in six patients). All but one PET/CT showed distant metastases.
PET/CT is a powerful tool to detect locoregional LNM and can particularly help identify cases where LNDs are required, avoiding reoperation later on. For accurate staging of the central neck, PET may be combined with diagnostic CT. Finally, PET/CT's ability to detect distant metastases may support de-escalation of a surgical intervention when cure is unlikely.
虽然甲状腺全切除术加中央区颈淋巴结清扫术(CND)是甲状腺髓样癌(MTC)的标准治疗方法,但是否进行侧颈淋巴结清扫术(LND)取决于局部区域转移扩散情况,通常需因人而异决定。本研究评估了术前PET/CT在诊断时对患者进行分期及指导初始手术方案的效用,同时探讨了颈部超声、MRI和CT的价值。
从两个回顾性数据库中识别出两家三级医院(2000 - 2020年)的所有MTC患者。回顾了所有在初次手术前8个月内或MTC诊断后4个月内的颈部超声、MRI、CT和PET/CT报告。确定了每种成像方式定位局部区域淋巴结转移(LNM)的敏感性和特异性。
共纳入175例MTC患者(91例女性,57例遗传性MTC)。就诊时的中位年龄为52岁(四分位间距38 - 62岁)。初始治疗包括155例(89%)患者行甲状腺全切除术、140例(80%)患者行CND以及59例(33%)患者行LND。颈部术前成像包括超声(91例,52%)、MRI(33例,19%)和CT(31例,18%)。56例(32%)患者进行了PET/CT成像(35例F-FDG PET/CT和33例F-DOPA PET/CT)。F-FDG PET/CT、F-DOPA PET/CT、超声、MRI和CT对中央区LNM的敏感性分别为72%、39%、6%、42%和93%。各自的特异性率分别为80%、100%、100%、71%和100%。F-FDG PET/CT、F-DOPA PET/CT、超声、MRI和CT对侧颈LNM的敏感性率分别为89%、81%、77%、76%和75%,而特异性率分别为100%、100%、75%、78%和50%。23例患者影像学检查发现有远处转移。这23例患者共进行了14例F-FDG PET/CT和9例F-DOPA PET/CT检查(6例患者同时进行了两种检查)。除1例PET/CT外,所有检查均显示有远处转移。
PET/CT是检测局部区域LNM的有力工具,尤其有助于识别需要行LND的病例,避免后期再次手术。对于中央颈部的准确分期,PET可与诊断性CT联合使用。最后,PET/CT检测远处转移的能力在不太可能治愈时可能支持降低手术干预的级别。